News
Owkin publishes breakthrough research in Nature Medicine
Novel deep-learning approach for predicting and explaining the…
Positive interactions with EMA provide route to conditional marketing authorization of lead candidate Nefecon
Calliditas Therapeutics AB (publ) (“Calliditas”) today…
Artios Pharma appoints Tania Dimitrova as Chief Business Officer and expands presence in the United States
Cambridge, UK and New York, US, 24 September 2019. Artios Pharma…
Neuraxpharm provides business update on a transformational year
Neuraxpharm Group (Neuraxpharm), a leading European specialty…
Optimum’s 11th Annual Healthcare Investor Conference
17 OCT 2019 | London
HOX THERAPEUTICS TO PRESENT AT 2019 AACR ANNUAL MEETING
Guildford, UK – 06 February 2019: HOX Therapeutics, the private…
DelSiTech and Innovare Sign Licensing Agreement for the Development of a Long Acting HIV Therapy
Turku, Finland – 18 December 2018: DelSiTech Ltd, a Finnish…
Optimum Strategic Communications Expands Investor Relations & Corporate Communications in Switzerland
Optimum Strategic Communications (Optimum), the international strategic healthcare communications firm, announces the strategic collaboration with Leti McManus to offer investor relations, corporate and financial communications in Switzerland.
Nuformix Expands Licensing Agreement with Newsummit Biopharma for cancer supportive care product
Receives First Milestone Payment for NXP001
Cambridge, UK,…
INKEF Capital Appoints Roel Bulthuis as Managing Director to Co-Manage Eur 500m Fund
Venture fund focuses on supporting early stage healthcare and…
Founder of Optimum Mary Clark to speak at SME Series Workshop on ‘Funding your Private Company’
SME SERIES | CENTRAL SWITZERLAND
First Workshop | Funding your…
Optimum Strategic Communications Appoints Leading Healthcare Investor Anne Marieke Ezendam
Renowned fund manager and buyside analyst joins investor relations…
Optimum Strategic Communications and Bloomberg Intelligence partner to debate the Future of Healthcare
Optimum Strategic Communications and Bloomberg Intelligence partner…
How is Tech transforming developments in healthcare?
Optimum Strategic Communications (Optimum), the international…
AGENDA & SPEAKERS: Optimum’s 10th Annual Healthcare Investor Conference at Bloomberg
Ten years ago, we held our first annual investor conference with…
How is Tech transforming developments in healthcare?
Optimum Strategic Communications (Optimum), the international strategic healthcare communications firm, will be hosting its 10th Annual Healthcare Investor Conference in partnership with Bloomberg Intelligence on Tuesday, 16 October 2018 at Bloomberg’s new European Headquarters in the City of London.
Optimum Strategic Communications announces partnership with Euronext on the TechShare Project
The Euronext TechShare project, is the only European programme…
The LSX C-Suite Challenges in Life Sciences Survey 2018
The majority of the questions in this LSX survey are multiple…
Life Sciences Investors Concerned Over Corporate Readiness for MIFID II
New investor survey highlights need for companies to significantly…
We’d love to hear from you.
For more information about Optimum Strategic Communications, please get in touch.
We are specialists with an indepth understanding of how to communicate complex science to investors and corporate stakeholders. We help companies on their journey as they grow and have been trusted by hundreds of clients from around the world, both public and private, large and small.
Locations
- London
- Amsterdam
- Stockholm
- Zurich
- New York
